Genzyme Halts Production At Mass. Plant Over Virus

Law360, New York (June 16, 2009, 12:00 AM EDT) -- Genzyme Corp. has detected a virus that impairs cell growth at its Allston, Mass., manufacturing facility and will need to temporarily halt production in order to sanitize the plant, the company said Tuesday.

The virus strain, Vesivirus 2117, has not been known to cause human infection but interferes with the growth of CHO cells used to produce biologic drugs. The company detected the virus in one of six bioreactors at its Allston Landing facility, one of the world's largest cell-culture manufacturing plants.

Genzyme's inventories for two...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.